The October 10 recall is due to the presence of N-nitroso-duloxetine, a chemical that is toxic if swallowed and is suspected of causing cancer, according to the National Library of Medicine. The FDA classified the recall as Class II, which means that the drug could cause "temporary or medically reversible adverse health consequences."
The medication, manufactured by Towa Pharmaceutical Europe, was distributed nationally throughout the U.S., according to the recall notice.
https://www.cbsnews.com/amp/news/duloxetine-recall-2024-name-brand-cymbalta-fda-chemical/
I am unburdened by what has been.
Responses